Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
作者信息
Miller L P, Miller D R, Tan C T
出版信息
Cancer Treat Rep. 1983 May;67(5):439-43.
PMID:6189604
Abstract
摘要
相似文献
1
2
Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):807-11.
3
[Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].[米托蒽醌的临床活性以及米托蒽醌与阿糖胞苷联合用药的临床活性]
Nouv Presse Med. 1982 Oct 9;11(39):2911-4.
4
Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.安吖啶（AMSA）联合化疗方案在急性白血病中的现状
Cancer Treat Rep. 1983 Nov;67(11):967-70.
5
6
Cyclocytidine in the treatment of refractory acute childhood leukemia: a Southwest Oncology Group Phase I-II study.
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1913-5.
7
Amsacrine in refractory acute leukemia.安吖啶治疗难治性急性白血病。
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):787-9.
8
Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
Cancer Treat Rep. 1979 Aug;63(8):1331-3.
9
Phase II study of amsacrine gluconate in refractory leukemia.葡萄糖酸胺苯吖啶治疗难治性白血病的II期研究
Cancer Treat Rep. 1983 Dec;67(12):1131-2.
10
m-AMSA: phase II trial in advanced lymphoma and leukemia.
Am J Clin Oncol. 1984 Aug;7(4):357-60.
Zotero 插件